Shibata, T., Ebata, T., Fujita, K., Shimokata, T., Maeda, O., Mitsuma, A., . . . Ando, Y. (2016). Optimal dose of gemcitabine for the treatment of biliary tract or pancreatic cancer in patients with liver dysfunction. Cancer Sci.
Citação norma ChicagoShibata, Takashi, Tomoki Ebata, Ken‐ichi Fujita, Tomoya Shimokata, Osamu Maeda, Ayako Mitsuma, Yasutsuna Sasaki, Masato Nagino, and Yuichi Ando. "Optimal Dose of Gemcitabine for the Treatment of Biliary Tract or Pancreatic Cancer in Patients With Liver Dysfunction." Cancer Sci 2016.
Citação norma MLAShibata, Takashi, et al. "Optimal Dose of Gemcitabine for the Treatment of Biliary Tract or Pancreatic Cancer in Patients With Liver Dysfunction." Cancer Sci 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.